Back to Stakeholders
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchIndependent Academic Research Groups
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & Manufacturing

Jiangsu HengRui Medicine Co., Ltd.

China
1 Trial

Jiangsu HengRui Medicine Co., Ltd. is one of China's largest publicly listed pharmaceutical companies, specializing in innovative drugs across oncology, anesthesia, and metabolic diseases. The company has developed HR071603, a proprietary ketamine nasal spray candidate, which entered Phase I clinical evaluation in healthy subjects.

Academic Research

0 papers

Published Papers

0

Trial Involvement

1

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
Public Biotech
HQ
China
Website
Visit

Sponsored Trials

1
CompletedI

A Study of HR071603 (Ketamine Nasal Spray) in Healthy Subjects

Start Date
Compounds
Ketamine, Placebo